Next Article in Journal
Immune-Related Functional Differential Gene Expression in Koi Carp (Cyprinus carpio) after Challenge with Aeromonas sobria
Previous Article in Journal
Recent Trends and Applications of Molecular Modeling in GPCR–Ligand Recognition and Structure-Based Drug Design
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Biotransformation of α-Acetylbutyrolactone in Rhodotorula Strains

by
Wanda Mączka
1,*,
Katarzyna Wińska
1,
Małgorzata Grabarczyk
1 and
Barbara Żarowska
2
1
Department of Chemistry, Wrocław University of Environmental and Life Sciences, Norwida 25, 50-375 Wrocław, Poland
2
Department of Biotechnology and Food Microbiology, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37/41, 51-630 Wrocław, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(7), 2106; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms19072106
Submission received: 5 July 2018 / Revised: 16 July 2018 / Accepted: 17 July 2018 / Published: 20 July 2018
(This article belongs to the Section Bioactives and Nutraceuticals)

Abstract

:
Due to its structural similarity, the α’-1′-hydroxyethyl-γ-butyrolactone obtained by reduction of (±)-α-acetyl-γ-butyrolactone may have a similar function in the body to γ-butyrolactone (GBL). In the work presented, biotransformation of α-acetyl-γ-butyrolactone by three Rhodotorula strains was performed obtaining enantiomerically enriched alcohol. The process was carried out in growing and resting cultures. We studied how both media composition and organic solvent volume affected stereoselectivity and effectiveness of biotransformation. After 2 h, the enantiomerically pure (3R, 1′S)-α’-1′-hydroxyethyl-γ-butyrolactone was obtained using the R. marina AM77 strain in YPG (Yeast extract-Peptone-Glucose) medium enriched with 5% glycerol. To our best knowledge there is no previous information in the literature about the (±)-α-acetyl-γ-butyrolactone biotransformation performed in medium with addition of organic and deep eutectic solvents.

Graphical Abstract

1. Introduction

Rhodotorula is included in the order Sporidiobolales, class Microbotryomycetes, and phylum Basidiomycota in the Fungi kingdom [1]. Species of this genus are ubiquitous saprophytic yeasts that can be acquired from many environmental sources including air, soil, grass, lakes, oceans, food, and human skin [1,2]. Rhodotorulas biomass can also be a valuable addition to animal feed because these strains synthetize carotenoids: β-carotene, torulene, and torularhodin (a typical feature of this species is red colour of cells) [3,4]. The lipid content in R. glutinis biomass can reach up to 60% [4].
In our study of effective reduction of (±)-α-acetyl-γ-butyrolactone 1, we chose Rhodotorula strains, because of their known ability to commonly reduce low-molecular-weight ketones—derivatives of acetophenone [5,6,7,8,9]—and ketoesters [10].
The product of α-acetylbutyrolactone reduction are enantiomers of α’-1′-hydroxyethyl-γ-butyrolactone 2, which could be potential central nervous system (CNS) ligands. This compound is a structural analog of γ-butyrolactone (GLB) which exerts several inhibitory actions over CNS through interaction with specific neuronal high-affinity receptors [11]. Additionally, because it is a bifunctional compound (lactone and alcohol), it could be a useful building block in asymmetric synthesis [12]. In biological tests it is essential to use compounds in their pure enantiomer forms, especially when synthesizing pharmaceuticals, where a high enantiomeric excess is required to prevent undesired side effects by the second enantiomer [13].
Contrarily, biotransformation could be ineffective, when substrates are toxic or have low solubility in water. Overcoming these limitations is accomplished by creating an organic-aqueous biphasic system. The aqueous phase constitutes a buffer or medium along with biocatalyst. The second phase is a water immiscible phase; therefore, both the substrate and the product strongly prefer this phase. During the reaction this phase acts as a substrate reservoir, and on the other hand as an in situ extractant for the product [14]. Presently, deep eutectic solvent (DES) is a new designer solvent, which is a mixture of two or more components. It forms a eutectic with the melting point lower than each individual component separately [15,16,17]. The most popular halide salt among all DES is choline chloride (ChCl), which is similar to B-class vitamins and it is a biodegradable and nontoxic salt [17]. As hydrogen bond donor (HBD) glycerol is most often used in DES. This compound is also the conventional solvent extensively used in food and pharmaceutical industries [18].
DES based on ChCl and glycerol is hydrophilic but its polarity does not influence catalytic activity. Viscosity has the ability to change enzyme activity in reaction systems by changing the mass-transfer limitations. DES are inexpensive, nontoxic, biodegradable, and do not require further purification [16].
In this paper, we describe biotransformation of (±)-α-acetyl-γ-butyrolactone 1 by means of Rhodotorula strains in both grown and resting cells culture in presence of different solvents and DES.

2. Results and Discussion

The first step of our investigation was the chemical reduction of (±)-α-acetyl-γ-butyrolactone 1 to obtain product standard, which was used in the chiral column (GC) analysis. The reaction was carried out according to the procedure worked out by Teixeira et al. [12]. As result of this chemical reaction we received anti-to-syn isomers of α’-1′-hydroxyethyl-γ-butyrolactone 2 in a ratio of 1:7. We used strain of Yarrowia lipolytica P26A to obtain (3R,1′R)-α’-1′-hydroxyethyl-γ-butyrolactone 2b [19] (Supplementary Materials). We compared the values of the specific rotation of obtained enantiomers of 2 with literature data [19,20]. To assign GC signals to the corresponding alcohol isomers, both chemically obtained 2 and the results of biotransformation of this substrate were used. As a result of the studies, it was possible to determine retention time of individual alcohol stereoisomers 2a2d (Figure 1).
Thus, we started a screening procedure using three yeast strains: Rhodotorula glutinis AM242, Rhodotorula marina AM77 and Rhodotorula rubra C9, which were grown in different media. YPG medium (Medium A) has a rich composition, as yeast extract is present alongside peptone as a source of nitrogen. We wanted to investigate if the change in nutrient composition would affect the transformation. We used the most universal Sabouraud medium (Medium B) only consisting of glucose and peptone, and lastly MCM (Mushroom Complete Medium) medium (Medium C) with a reduced amount of peptone and yeast supplemented with mineral salts. The samples were collected after 1, 2, 3, 4 and 5 h (Table 1, Table 2 and Table 3).
In the case of α-acetylbutyrolactone 1 transformation by the R. glutinis AM242 strain, the highest degree of conversion was observed in medium A (YPG) (Table 1). The substrate was transformed for five days, thereafter the amount of unreacted substrate was less than 35%. In addition, the presence of 1% yeast extract in the medium facilitated the formation of the anti diastereoisomer. In the other media, a constant dominance of the syn diastereoisomer was observed. In addition, when using B and C media, the biotransformation process was much slower, because after five days, about 70% of the unreacted substrate remained.
The R. marina AM77 strain was found to be a much better biocatalyst in the transformation of 1 than R. glutinis AM242 because the complete substrate conversion occurred in just 3 h both in Medium A and B (Table 2). The presence of peptone as a source of nitrogen in concentration of at least 1% (S) seems to be significant for substrate conversion.
In the case of 1 biotransformation by the R. rubra C9 strain, the highest substrate conversion and transformation diastereoselectivity were observed using YPG medium (Medium A) (Table 3). This strain proved to be a much better biocatalyst than R. glutinis AM242 and comparable to R. marina AM77 in terms of reactivity of the substrate, considering that complete substrate conversion was achieved after three hours of transformation. The use of B or C media increased the biotransformation time to four hours.
The subsequent stage of our research was to investigate the stereoselectivity in biotransformation. The tests were performed in the optimal medium identified for each strain in the initial studies. Transformations were finished after three hours in the cases of R. rubra C9 and R. marina AM77, and after five hours for R. glutinis AM242 (Table 4).
The main product of the transformation of α-acetylbutyrolactone 1 using all strains was the 2d stereoisomer, with the exception of R. glutinis AM242 strain where in biotransformation the formation of all four stereoisomers was observed.
The presence of enol (Table 1, Table 2 and Table 3) as well as the low diastereoselectivity and enantioselectivity of the transformation 1 by R. glutinis AM242 (Table 4) is in accordance with mechanism described by Ribeiro [11]. The formation of all four stereoisomers is due to the reduction of both the enol and the carbonyl group of 1.
In the consecutive experiment, biotransformation of substrate 1 in resting culture was investigated. For this purpose, the harvested cells was suspended in phosphate buffer at pH = 7. Biotransformations were carried out for two days with sampling at 3, 5, 8, 24 and 48 h. The sampling was finished after complete conversion of substrate 1 (Table 5).
In this case, the time required to complete conversion of substrate 1 was prolonged in comparison to the results presented previously. R. glutinis AM242 required 48 h for complete conversion, and strains of R. marina AM77 and R. rubra C9 needed 8 h and 5 h, respectively. The highest enantioselectivity was observed for the R. marina AM77 strain, as only products 2b and 2d were obtained. The strain of R. rubra C9 was also capable of producing an enantiomerically pure 2d enantiomer and a mixture of 2a and 2b isomers with the latter’s superiority.
Because the medium contains a high concentration of glucose, which facilitates the regeneration of enzyme cofactors, we have decided to check whether the addition of sugar will favour biotransformation of 1. For this purpose, in next experiment, the 1% glucose was added to harvested cells of Rhodotorula strains suspended in phosphate buffer at pH = 7 (Table 6).
Glucose supplementation did not significantly affect transformations using the resting cell culture of R. glutinis AM242. More differences were examined in the other two strains. However, R. marina AM77 and R. rubra C9 strains formed 2a isomer in addition to the 2b isomer, which reduced the enantiomeric excess of stereoisomer syn. Furthermore, R. rubra C9 strain exhibited a significant increase in the percentage of pure enantiomerically 2d stereoisomer.
In the last phase of our study we examined the effect of solvent addition on the substrate conversion. The studies were carried out using strain of R. marina AM77, while taking into account both types and amounts of solvent applied. The biotransformation was finished after 2 h (Table 7).
In the aforementioned experiments (Table 4, Table 5 and Table 6), the formation of all four stereoisomers of 2 in different proportions was observed. Each organic solvent added to the medium had individually different although significant effects on diastereo- and enantioselectivity of biotransformation. In almost all cases (except for the presence of 20% glycerol), the formation of the stereoisomer 2d alone was observed. Presence of solvent in transformation mixture may have inhibited enzymes responsible for reduction of the double bond in enol. Hence the 2d stereoisomer was produced by stereoselective reduction of the carbonyl group. Unfortunately, the addition of solvents had a negative effect on the substrate’s reactivity. Total conversion of 1 occurred only in one transformation, associated with adding 5% glycerol to the medium.
In case of carbonyl reductase, 2-propanol can be used as co-substrate for regeneration of NAD+ or NADP+ and increases substrate solubility [21]. Supplementation with isopropanol (5%) improved the stereoselectivity of the transformation. A considerably larger amount of isopropanol (20%) completely inhibits enzymes responsible for this transformation. In turn, ethanol proved to be an interesting alternative to glucose as co-substrate to regenerate cofactors. However, it is toxic to the cells at higher concentration [22].
Scrutinizing the results for full conversion of substrate 1 to one (3R, 1′S)-enantiomer 2d after two hours, the transformation by R. marina AM77 in presence of 5% glycerol was chosen for preparative scale biotransformation. Next, optical rotation was determined after purification of 2d by means of column chromatography. The obtained value of optical rotation ( [ a ] 20 D   = +18.4 (c = 0.7; CHCl3), was compared with literature data to confirm configuration of the biotransformation product [20].
Meanwhile biotransformation 1 performed by the R. marina AM77 strain in medium coupled with glycerol had a favourable effect on the process. Next, we carried out transformation in a phosphate buffer pH = 7 with DES. The deep eutectic solvent was a mixture of choline chloride and glycerol in a ratio of 1:2 or a mixture of chloride choline, glycerol and glucose in a ratio of 1:2:1. The samples were collected after 5 h, 1 day, 2 days, 4 days and 7 days (Table 8).
The use of DES in biotransformations by means of resting cells negatively affected the process. The addition of DES resulted in significant prolonged time of all biotransformations and reduced stereoselectivity. More frequently, the isomers 2a, 2b and 2d were formed. Formation of pure isomers 2b and 2d in combination with complete conversion of substrate 1 was observed only in the presence of ChCl:Gly at 10% and ChCl:Gly:Glc at 25%.

3. Materials and Methods

3.1. Analysis

Progress of all biotransformations and purity of isolated products were checked by TLC on silica gel-coated aluminium plates (DC-Alufolien Kieselgel 60 F254, Merck, Darmstadt, Germany) and also by GC analysis performed on a CP03380 instrument (Varian, Agilent Technologies, Santa Clara, CA, USA) using an DB-1 column (dimethylpolysiloxane, Agilent, 30 m × 0.25 mm × 0.25 µm). Temperatures during GC analysis were as follows: injector 250 °C, detector (FID) 300 °C, column temperature: 75 °C (hold 3 min), 75–80 °C (rate 2 °C/min), 80–150 °C (rate 17 °C/min), 150–300 (rate 40 °C/min), 300 °C (hold 1 min). The enantiomeric excess of the products obtained during biotransformation were determined by GC analysis using chiral column Gamma DEXTM 325 (30 m × 0.25 mm × 0.25 µm, Supelco, Bellefonte, PA, USA) under the following conditions: injector 150 °C, detector (FID) 250 °C, column temperature: 80 °C (hold 20 min), 80–107 °C (rate 1 °C/min), 107–200 °C (rate 30 °C/min), 200 °C (hold 1 min). All products were purified using preparative column chromatography on silica gel (Kieselgel 60, 230–400 mesh). NMR spectra were recorded with a Bruker Avance DRX-500 spectrometer in CD3OD solution. Optical rotations were measured on P-2000 polarimeter (Jasco, Easton, PA, USA).

3.2. Synthesis of Standards

The chemical reduction of α-acetylbutyrolactone 1 was carried out according to the procedure worked out by Teixeira et al. [12]. α-Acetylbutyrolactone 1 (1 g, 7.8 mmol) in 30 mL of methanol was stirred for 30 min at room temperature in the presence of CaCl2 (1.73 g, 15.6 mmol). Next, the reaction mixture was cooled to 0 °C and NaBH4 was slowly added. When reaction was complete, crude product was extracted by diethyl ether (3 × 15 mL) and dried over MgSO4. After evaporation 0.68 g of α’-1′-hydroxyethyl-γ-butyrolactone 2 was obtained.
1H NMR (500 MHz, CD3OD, Figure S1): 1.25 (d, J = 7.0 Hz, 3H, CH3-2′B), 1.26 (d, J = 6.4 Hz, 3H, CH3-2′A), 1.22–1.24 (dq, J = 12.8 and 8.5 Hz, 1H, one of CH2-2A), 2.22–2.30 (m, 1H, one of CH2-2B), 2.32–2.39 (m, 2H, one of CH2-2A and one of CH2-2B), 2.65 (ddd, J = 9.4, 9.4 and 3.3 Hz, 1H, H-3B), 2.74 (ddd, J = 9.4, 8.8 and 4.7 Hz, 1H, H-3A), 4.05 (dq, J = 6.4 and 4.8 Hz, 1H, 1′A), 4.22–4.27 (m, 2H, CH2-1A), 4.33–4.38 (m, 3H, CH2-1B and 1′B).

3.3. Microorganisms

The yeast strains of Rhodotorula glutinis AM242, Rhodotorula marina AM77, Rhodotorula rubra C9 were used in this research. The microorganisms were obtained from collection of the Department of Chemistry or the Department of Biotechnology and Food Microbiology at Wroclaw University of Environmental and Life Sciences (Wrocław, Poland). Stock cultures of these strains were maintained on a gelified medium (glucose 20 g/L, peptone 20 g/L, yeast extract 10 g/L and agar 20 g/L) and were stored at 4 °C.

3.4. Cultivation Media

Medium A (YPG) was composed of: (g/L) glucose (20), peptone (20), yeast extract (10).
Medium B was composed of: (g/L) glucose (30), peptone (10).
Medium C (MCM) was composed of: (g/L) glucose (20), peptone (2.0), yeast extract (2.0), KH2PO4 (0.49), K2HPO4 (1.0), MgSO4 × 7H2O (0.5).

3.5. Screening Procedure

The microorganisms were cultivated at 25 °C in 300 mL Erlenmeyer flasks containing 50 mL of the appropriate medium. After 4 days of growth, 50 µL of substrate (0.060 g, 7.8 mmol) was added to the shaken cultures. The transformation was continued for maximum 4 days. The medium (20 mL) contained unreacted substrate, product and mycelium were extracted with ethyl acetate (20 mL). The organic fraction were dried over anhydrous magnesium sulphate and the solvent was evaporated in vacuo and analysed by GC (DB-1 column).

3.6. Preparative Biotransformation

The culture of Rhodotorula marina AM77 (50 mL, 12.0 g/L) was centrifuged at 5000 rpm for 3 min. The culture was re-suspended in two flasks with 100 mL of sterile medium with addition of 5% glycerol. In next step, the substrate (100 mg) was added. After two hours, the medium, which contained product and mycelium was extracted three times with ethyl acetate (100 mL). The organic fraction were dried over anhydrous magnesium sulphate, the solvent was evaporated in vacuo and analysed by GC (chiral column). Product of biotransformation was purified by means of column chromatography (Kieselgel 60, 230–400 mesh; hexane:diethyl ether 1:1, 67 mg, 67%). Next, the optical rotation was determined. The obtained value of optical rotation ( [ a ] 20 D = +18.4 (c = 0.7; CHCl3) was compared with literature data [20]. Therefore, the biotransformation product is (3R, 1′S)-α’-1′-hydroxyethyl-γ-butyrolactone (2d).

3.7. Preparation of Resting Cell Suspension

The cultivated cells were harvested by centrifugation (5000 rpm, 3 min) at 4 °C and washed three times with distilled water. Resting cells of microorganism were re-suspended in 40 mL of 0.1 M phosphate buffer (KH2PO4 + Na2HPO4, pH = 7.0) to make a resting cell suspension (6.0 g/L).

3.8. Biotransformation in the Presence of Organic Solvents

The culture of microorganism (20 mL, 12.0 g/L) was centrifuged at 5000 rpm for 3 min. The culture was re-suspended in 50 mL of sterile medium with addition of appropriate organic solvent (ethanol, isopropanol, glycerol, hexane). In the next step the substrate was added. After suitable time, the medium (20 mL), which contained unreacted substrate, product and mycelium were extracted with ethyl acetate (20 mL). The organic fraction were dried over anhydrous magnesium sulphate and the solvent was evaporated in vacuo and analysed by GC (chiral column).

3.9. Biotransformation in the Presence of Deep Eutectic Solvents

In the experiment we either mixed choline chloride (ChCl, 1 mol) with glycerol (Gly, 2 mol) or 2 mol of ChCl with glycerol (1 mol) and glucose (Glc, 1 mol). All DES were maintained at 80 °C for 2 h until a homogeneous liquid was achieved.
The culture of microorganism (20 mL, 12.0 g/L) was centrifuged at 5000 rpm for 3 min. The culture was then re-suspended in 40 mL of sterile phosphate buffer (0.1 M, pH = 7) and then added to appropriate DES (10%, 25%, or 50%). Next, the substrate was added. After a suitable transformation time the medium (20 mL) with unreacted substrate, product and mycelium were extracted with ethyl acetate (20 mL). The organic fraction were dried over anhydrous magnesium sulphate and the solvent was evaporated in vacuo and analysed by GC (chiral column).

4. Conclusions

The several biotransformations of α-acetylbutyrolactone 1 were performed using three strains of yeast: R. glutinis AM242, R. marina AM77 and R. rubra C9. The YPG was optimal medium for biotransformation. All strains were capable of converting (±)-α-acetyl-γ-butyrolactone 1 to α’-1′-hydroxyethyl-γ-butyrolactone 2. Out of the four possible stereoisomers, the most common product was (+)-(3R, 1′S)-α’-1′-hydroxyethyl-γ-butyrolactone (2d). The complete conversion of 1 to 2 occurred within 3 hours for strains R. marina AM77 and R. rubra C9. The use of resting cells resulted in an increase of reaction time, while R. marina AM77 also increased in the enantioselectivity of the process. The addition of 1% glucose to resting cells did not significantly affect the course of biotransformation. Supplementing the YPG medium with different organic solvents had a positive effect on enantioselectivity. Predominantly (with the exception of 20% glycerol) the 2d stereoisomer was formed only. Unfortunately, the degree of reactivity of 1 decreased considerably. Total conversion of the substrate occurred only in the presence of 5% glycerol. The addition of deep eutectic solvents to yeast resting cells culture negatively affected the course of transformation. There was an increase in biotransformation time and a decrease in stereoselectivity with respect to the pair of syn enantiomers. Total reactivity of substrate 1 occurred only when ChCl:Gly was used at 10% and ChCl:Gly:Glc at 25%. In both cases, formation of stereoisomers 2b and 2d with high enantiomeric excess was observed.

Supplementary Materials

Supplementary materials can be found at https://0-www-mdpi-com.brum.beds.ac.uk/1422-0067/19/7/2106/s1.

Author Contributions

W.M. conceived, designed the experiments and analysed the data, W.M. and K.W. performed the experiments, W.M. and M.G. wrote the paper, B.Ż. supplied some microbiological strains and conducted microbiological consultation.

Funding

This research received no external funding.

Acknowledgments

Publication supported by Wrocław Centre of Biotechnology, The Leading National Research Centre (KNOW) programme for 2014–18.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kot, A.M.; Błażejak, S.; Kurcz, A.; Gientka, I.; Kieliszek, M. Rhodotorula glutinis—Potential source of lipids, carotenoids, and enzymes for use in industries. Appl. Microbiol. Biotechnol. 2016, 100, 6103–6117. [Google Scholar] [CrossRef] [PubMed]
  2. Wirth, F.; Goldani, L.Z. Epidemiology of Rhodotorula: An emerging pathogen, interdisciplinary perspectives on infectious diseases. Interdiscip. Perspect. Infect. Dis. 2012, 2012, 1–7. [Google Scholar] [CrossRef] [PubMed]
  3. Banzatto, D.; Aline de Freita, L.; Rossini Mutton, M.J. Carotenoid production by Rhodotorula rubra cultivated in sugarcane juice, molasses, and syrup. Ciênc. Tecnol. Aliment. 2013, 33, 14–18. [Google Scholar] [CrossRef]
  4. Kot, A.M.; Błażejak, S.; Kurcz, A.; Bryś, J.; Gientka, I.; Bzducha-Wróbel, A.; Maliszewska, M.; Reczek, L. Effect of initial pH of medium with potato wastewater and glycerol on protein, lipid and carotenoid biosynthesis by Rhodotorula glutinis. Electron. J. Biotechnol. 2017, 27, 25–31. [Google Scholar] [CrossRef]
  5. Aguirre-Pranzoni, C.; Bisogno, F.R.; Orden, A.A.; Kurina-Sanz, M. Lyophilized Rhodotorula yeast as all-in-one redox biocatalyst: Access to enantiopure building blocks by simple chemoenzymatic one-pot procedures. J. Mol. Catal. B Enzym. 2015, 114, 19–24. [Google Scholar] [CrossRef]
  6. Janeczko, T.; Dymarska, M.; Kostrzewa-Susłow, E. Highly enantioselective production of (R)-halohydrins with whole cells of Rhodotorula rubra KCh 82 culture. Int. J. Mol. Sci. 2014, 15, 22392–22404. [Google Scholar] [CrossRef] [PubMed]
  7. Janeczko, T.; Kostrzewa-Susłow, E. Enantioselective reduction of propiophenone formed from 3-chloropropiophenone and stereoinversion of resulting alcohols in selected yeast cultures. Tetrahedron Asymmetry 2014, 25, 1264–1269. [Google Scholar] [CrossRef]
  8. De Oliveira Lopes, R.; Benzaquem Ribeiro, J.; de Souza Ramos, A.; Miranda, L.S.M.; Ramos Leal, I.C.; Gomes Ferreira Leite, S.; Mendoça Alves de Souza, R.O. Highly enantioselective bioreduction of bromoacetophenone. Tetrahedron Asymmetry 2011, 22, 1763–1766. [Google Scholar] [CrossRef]
  9. Fardelone, L.C.; Rodrigues, J.A.R.; Moran, P.J.S. Bioreduction of 2-azido-1-arylethanones mediated by Geotrichum candidum and Rhodotorula glutinis. J. Mol. Catal. B Enzym. 2006, 39, 9–12. [Google Scholar] [CrossRef]
  10. De Souza Ramos, A.; Benzaquem Ribeiro, J.; de Oliveira Lopes, R.; Mendonc, R.O.; de Souza, A. Whole cells in enantioselective reduction of tert-butyl acetoacetate. Synth. Commun. 2013, 43, 1611–1618. [Google Scholar] [CrossRef]
  11. Benzaquem Ribeiro, J.; Andrade de Sousa, L.M.; da Volta Soares, M.; da Conceição, M.; Ramos, K.V.; Aquino Neto, F.R.; Mansour Fraga, C.A.; Ferreira Leite, S.G.; Cordeiro, Y.; Antunes, O.A.C. Microbial reduction of α-acetyl-γ-butyrolactone. Tetrahedron Asymmetry 2006, 17, 984–988. [Google Scholar] [CrossRef]
  12. Teixeira, L.H.P.; de Souza, M.C.B.V.; da Conceição, K.V.; Ramos, M.; de Aquino Neto, F.R.; Barreiro, E.J.; Fraga, C.A.M. Studies on the diastereoselective reduction of 2-acetyl-2-alkyl-γ-butyrolactones with boron hydrides. Synth. Commun. 2002, 32, 505–526. [Google Scholar] [CrossRef]
  13. Bräutigam, S.; Dennewald, D.; Schürmann, M.; Lutje-Spelberg, J.; Pitner, W.-R.; Weuster-Botz, D. Whole-cell biocatalysis: Evaluation of new hydrophobic ionic liquids for efficient asymmetric reduction of prochiral ketones. Enzym. Microb. Technol. 2009, 45, 310–316. [Google Scholar] [CrossRef]
  14. Dennewald, D.; Pitner, W.-R.; Weuster-Botz, D. Recycling of the ionic liquid phase in process integrated biphasic whole-cell biocatalysis. Proc. Biochem. 2011, 46, 1132–1137. [Google Scholar] [CrossRef]
  15. Abbott, A.P.; Capper, G.; Davies, D.L.; Rasheed, R.K.; Tambyrajah, V. Novel solvent properties of choline chloride/urea mixtures. Chem. Commun. 2003, 1, 70–71. [Google Scholar] [CrossRef]
  16. Juneidi, I.; Hayyana, M.; Hashim, M.A. Intensification of biotransformations using deep eutectic solvents: Overview and outlook. Process Biochem. 2018, 66, 33–60. [Google Scholar] [CrossRef]
  17. Abo-Hamad, A.; Hayyan, M.; AlSaadi, M.A.; Hashim, M.A. Potential application of deep eutectic solvents in nanotechnology. Chem. Eng. J. 2015, 273, 551–567. [Google Scholar] [CrossRef]
  18. AlOmar, M.K.; Hayyan, M.; Alsaadi, M.A.; Akib, S.; Hayyan, A.; Hashim, M.A. Glycerol-based deep eutectic solvents: Physical properties. J. Mol. Liq. 2016, 215, 98–103. [Google Scholar] [CrossRef]
  19. Fantin, G.; Fogagnolo, M.; Giovannini, P.P.; Medici, A.; Pedrini, P.; Gardini, F.; Lanciotti, R. Anti-Prelog microbial reduction of prochiral carbonyl compounds. Tetrahedron 1996, 52, 3547–3552. [Google Scholar] [CrossRef]
  20. Fantin, G.; Fogagnolo, M.; Giovannini, P.; Medici, A.; Pagnotta, E.; Pedrini, P.; Trincone, A. Synthesis of homochiral syn- and anti-α-(hydroxyethyl)-γ-buttyrolactones via microbial reduction. Tetrahedron Asymmetry 1994, 5, 1631–1634. [Google Scholar] [CrossRef]
  21. Xu, Q.; Xu, X.; Huang, H.; Li, S. Efficient synthesis of (R)-2-chloro-1-phenylethol using a yeast carbonyl reductase with broad substrate spectrum and 2-propanol as cosubstrate. Biochem. Eng. J. 2015, 103, 277–285. [Google Scholar] [CrossRef]
  22. Johanson, T.; Katz, M.; Gorwa-Grauslund, M.F. Strain engineering for stereoselective bioreduction of dicarbonyl compounds by yeast reductases. FEMS Yeast Res. 2005, 5, 513–525. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Structures of substrate 1 and stereoisomers of product 2.
Figure 1. Structures of substrate 1 and stereoisomers of product 2.
Ijms 19 02106 g001
Table 1. The results of biotransformation of α-acetylbutyrolactone 1 by R. glutinis AM242 in different media (in % according to GC (chiral column)). YPG: Yeast extract-Peptone-Glucose medium; MCM: Mushroom Complete Medium.
Table 1. The results of biotransformation of α-acetylbutyrolactone 1 by R. glutinis AM242 in different media (in % according to GC (chiral column)). YPG: Yeast extract-Peptone-Glucose medium; MCM: Mushroom Complete Medium.
StrainMediumTime
(h)
SubstrateStereoisomers of Productenol
(%)
1
(%)
2a + 2b (syn)
(%)
2c + 2d (anti)
(%)
de
(%)
Rhodotorula glutinis AM242A (YPG)183.34.62.726.09.4
275.38.98.05.37.8
366.313.514.32.95.8
452.117.827.521.42.6
534.922.640.127.92.4
B (S)185.67.81.469.55.2
282.510.72.562.13.7
378.513.74.550.53.3
470.317.39.031.53.4
567.015.610.021.97.4
C (MCM)183.55.70.583.910.3
282.36.61.269.29.9
378.610.42.857.68.2
472.911.65.138.910.4
570.212.26.034.111.5
Table 2. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in different media (in % according to GC (chiral column)).
Table 2. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in different media (in % according to GC (chiral column)).
StrainMediumTime
(h)
SubstrateStereoisomers of Productenol
(%)
1
(%)
2a + 2b (syn)
(%)
2c + 2d (anti)
(%)
de
(%)
Rhodotorula marina AM77A (YPG)177.86.88.18.77.2
236.015.837.841.110.4
3021.367.652.111.1
B (S)186.34.08.737.00.9
250.111.833.147.45.0
3019.477.259.83.3
C (MCM)186.44.02.817.66.7
279.65.57.012.07.7
348.111.234.050.46.7
48.214.868.364.48.7
5012.859.864.727.3
Table 3. The results of biotransformation of α-acetylbutyrolactone 1 by R. rubra C9 in different media (in % according to GC (chiral column)).
Table 3. The results of biotransformation of α-acetylbutyrolactone 1 by R. rubra C9 in different media (in % according to GC (chiral column)).
StrainMediumTime
(h)
SubstrateStereoisomers of Productenol
(%)
1
(%)
2a + 2b (syn)
(%)
2c + 2d (anti)
(%)
de
(%)
Rhodotorula rubra C9A (YPG)120.912.862.466.03.9
20.614.283.170.81.8
3010.189.979.80
B (S)184.67.44.029.84.0
272.69.412.614.55.4
343.917.534.532.74.1
4024.873.449.51.8
C (MCM)185.26.62.151.76.0
276.910.88.313.14.0
333.426.632.19.47.9
4034.460.227.35.3
Table 4. The results of biotransformation of α-acetylbutyrolactone 1 (in % according to GC (chiral column)).
Table 4. The results of biotransformation of α-acetylbutyrolactone 1 (in % according to GC (chiral column)).
StrainTime
(h)
1
(%)
synee
(%)
antiee
(%)
2a (3S, 1′S)
(%)
2b (3R, 1′R)
(%)
2c (3S, 1′R)
(%)
2d (3R, 1′S)
(%)
Rhodotorula glutinis AM242539.33.717.965.71.238.093.9
Rhodotorula marina AM77302.716.471.7080.9100
Rhodotorula rubra C9301.76.860.0091.5100
Table 5. The results of biotransformation of α-acetylbutyrolactone 1 in buffer solution (in % according to GC (chiral column)).
Table 5. The results of biotransformation of α-acetylbutyrolactone 1 in buffer solution (in % according to GC (chiral column)).
StrainTime
(h)
1
(%)
synee
(%)
antiee
(%)
2a (3S, 1′S)
(%)
2b (3R, 1′R)
(%)
2c (3S, 1′R)
(%)
2d (3R, 1′S)
(%)
Rhodotorula glutinis AM242390.20.35.890.203.7100
587.20.37.392.10.25.192.4
881.40.49.287.30.38.793.5
242.43.635.781.70.758.697.6
4803.93680.00.959.296.0
Rhodotorula marina AM77340.605.7100053.7100
56.205.5100088.3100
8001.6100098.3100
Rhodotorula rubra C937.84.616.857.0070.8100
504.617.458.2078.0100
Table 6. The results of biotransformation of α-acetylbutyrolactone 1 in buffer solution with 1% glucose (in % according to GC (chiral column)).
Table 6. The results of biotransformation of α-acetylbutyrolactone 1 in buffer solution with 1% glucose (in % according to GC (chiral column)).
StrainTime
(h)
1
(%)
synee
(%)
antiee
(%)
2a (3S, 1′S)
(%)
2b (3R, 1′R)
(%)
2c (3S, 1′R)
(%)
2d (3R, 1′S)
(%)
Rhodotorula glutinis AM2423100000000
589.60.45.185.504.9100
878.50.67.384.4013.6100
2417.63.632.780.20.645.497.4
4803.437.283.01.158.396.0
Rhodotorula marina AM773570.96.274.6035.9100
51.31.89.668.0087.3100
800.96.776.3092.4100
Rhodotorula rubra C932.94.610.639.0081.9100
503.85.417.4090.8100
Table 7. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in mixtures of Medium A and different solvents in different proportions (in % according to GC (chiral column)) after 2 h.
Table 7. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in mixtures of Medium A and different solvents in different proportions (in % according to GC (chiral column)) after 2 h.
Solvent% of Solvent1
(%)
synee
(%)
antiee
(%)
2a (3S, 1′S)
(%)
2b (3R, 1′R)
(%)
2c (3S, 1′R)
(%)
2d (3R, 1′S)
(%)
ethanol552.2000047.8100
1087.2000012.8100
2099.500000.5100
glycerol500000100100
107.8000092.2100
2080.62.81.627.0015100
hexane573.9000026.1100
1090.800009.2100
20100000000
isopropanol576.7000023.3100
1098.800001.2100
20100000000
Table 8. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in resting cells culture in the presence of different deep eutectic solvents (DES) (in % according to GC (chiral column)).
Table 8. The results of biotransformation of α-acetylbutyrolactone 1 by R. marina AM77 in resting cells culture in the presence of different deep eutectic solvents (DES) (in % according to GC (chiral column)).
DESTime1 (%)synee
(%)
antiee
(%)
2a (3S, 1′S)
(%)
2b (3R, 1′R)
(%)
2c (3S, 1′R)
(%)
2d (3R, 1′S)
(%)
ChCl:Gly 10%5 h1.504.4100094.1100
1 d004.7100095.3100
ChCl:Gly 25%5 h10000-00-
1 d2.42.012.873.0082.8100
2 d02.113.372.7084.6100
ChCl:Gly 50%5 h10000-00-
1 d88.81.36.265.303.7100
4 d31.44.835.476.0027.9100
7 d1.65.239.876.9053.4100
ChCl:Gly 66%5 h10000-00-
1 d93.70.74.070.201.6-
4 d76.33.214.764.005.8100
7 d55.28.824.663.2011.4100
ChCl:Gly:Glc 10%5 h4.91.614.380.0079.2100
1 d01.45.861.0092.8100
ChCl:Gly:Glc 25%5 h81.202.5100016.3100
1 d0013.6100086.4100
ChCl:Gly:Glc 50%1 d83.71.78.266.006.4100
4 d32.46.233.869.0027.3100
7 d29.56.531.566.0031.8100
ChCl:Gly:Glc 66%5h10000-00-
1 d10000-00-
4 d92.50.63.067.003.2100
7 d87.52.16.065.004.4100
ChCl:Gly—choline chloride and glycerol 1:2; ChCl:Gly:Glc—choline chloride, glycerol, and glucose 2:1:1. d: days.

Share and Cite

MDPI and ACS Style

Mączka, W.; Wińska, K.; Grabarczyk, M.; Żarowska, B. Biotransformation of α-Acetylbutyrolactone in Rhodotorula Strains. Int. J. Mol. Sci. 2018, 19, 2106. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms19072106

AMA Style

Mączka W, Wińska K, Grabarczyk M, Żarowska B. Biotransformation of α-Acetylbutyrolactone in Rhodotorula Strains. International Journal of Molecular Sciences. 2018; 19(7):2106. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms19072106

Chicago/Turabian Style

Mączka, Wanda, Katarzyna Wińska, Małgorzata Grabarczyk, and Barbara Żarowska. 2018. "Biotransformation of α-Acetylbutyrolactone in Rhodotorula Strains" International Journal of Molecular Sciences 19, no. 7: 2106. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms19072106

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop